Biogen Inc.

Biogen Inc. is a biotechnology company that focuses on discovering, developing, and delivering innovative therapies for the treatment of neurological diseases and related conditions. Founded in 1978 and headquartered in Cambridge, Massachusetts, Biogen is a pioneer in neuroscience, aiming to transform the standards of care through cutting-edge science and technology. The company is renowned for its extensive research and development efforts in areas like multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy. Biogen's product portfolio includes therapies that address significant unmet medical needs, impacting healthcare and patient well-being across the globe. As an influential entity in the biotechnology sector, Biogen collaborates with other industry leaders and research institutions to advance its mission of improving lives through remarkable biotechnological solutions.